Recent Finacing
Recent Raise
Complix develops cell-penetrating Alphabody™ protein therapeutics and a CPAB platform to target intracellular cytosolic and nuclear targets in oncology, autoimmunity and infectious disease, with labs in Hasselt, Ghent and Luxembourg.
